Does distance to treatment centre influence the rate of palliative radiotherapy in adult cancer patients?

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2641-2644

  Nieder, Carsten ^a,b,e   Norum, Jan ^b,c,d   Spanne, Oddvar ^d   Bilberg, Ingvild ^a   Vagstad, Geirfinn ^a   Dalhaug, Astrid ^a  

^a Department of Internal Medicine   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Northern Norway Regional Health Authority   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e Radiation Oncology Unit   (Norway)

Author keywords

Cancer; Palliative radiation treatment; Radiotherapy; Travel distance

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CENTER; CANCER PATIENT; CONTROLLED STUDY; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; NORWAY; PALLIATIVE THERAPY; PRIORITY JOURNAL; RESIDENTIAL AREA; TRAVEL;

ADULT; CANCER CARE FACILITIES; HUMANS; NEOPLASMS; NORWAY; PALLIATIVE CARE; PROSPECTIVE STUDIES; TRAVEL;

EID: 69249161782     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Solomans J and Mackillop WJ: Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19: 137-144, 2001. (Pubitemid 32063490)
2. Punglia RS, Weeks JC, Neville BA and Earle CC: Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 66: 56-63, 2006.
3. Celaya MO, Rees R, Gibson JJ, Riddle BL and Greenberg ER: Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States). Cancer Causes Control 17: 851-856, 2006.
4. Pagano E, Di Cuonzo D, Bona C, Baldi I, Gabriele P, Ricardi U, Rotta P, Bertetto O, Appiano S, Merletti F, Segnan N and Ciccone G: Accessibility as a major determinant of radiotherapy underutilization: a population based study. Health Policy 80: 483-491, 2007. (Pubitemid 46127712)
5. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H and Forman D: Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer 44: 992-999, 2008.
6. Hayman JA, Abrahamse PH, Lakhani I, Earle CC and Katz SJ: Use of palliative radiotherapy among patients with metastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys 69: 1001-1007, 2007. (Pubitemid 47625852)
7. Kong W, Zhang-Salomons J, Hanna TP and Mackillop WJ: A population-based study of the fractionation of palliative radiotherapy for bone metastasis in Ontario. Int J Radiat Oncol Biol Phys 69: 1209-1217, 2007. (Pubitemid 47625843)
8. Möller TR, Brorsson B, Ceberg J, Frödin JE, Lindholm C, Nylén U, Perfekt R; SBU survey group: A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 42: 387-410, 2003.
9. Norwegian Radiation Protection Authority. Virksomhetsrapport for norske stråleterapisentre 2003-2004 (Norwegian). Strålevern Rapport 2006: 11. Østerås: Statens strålevern, 2006.
10. Nieder C, Milas L and Ang KK: Tissue tolerance to reirradiation. Semin Radiat Oncol 10: 200-209, 2000.
11. Nieder C, Grosu AL, Andratschke N and Molls M: Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys 66: 1446-1449, 2006. (Pubitemid 44778962)